EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS116-23559 
Organism
Homo sapiens 
Tissue/cell
Left_ventricle 
Coordinate
chr3:46106620-46107660 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
NFKB1MA0105.4chr3:46106914-46106927TGGGGAATCCCCC+6.13
NFKB1MA0105.4chr3:46106914-46106927TGGGGAATCCCCC-6.14
RREB1MA0073.1chr3:46107079-46107099CACCCAACCACACACAGCCC+6.08
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_59476chr3:46098871-46141336Ly3
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr34610664146107090
Number: 1             
IDChromosomeStartEnd
GH03I046065chr34610652146107661
Enhancer Sequence
AGAGTTACCC AGCCAAGCTC TACTCAACTT TCTGGGTCAC AAAATTATAA GATCTAATAA 60
AATGGTTCTT TTAAGCCTCT ACATTTTGGG GCACTTTGTT ATGTAGCAAT AGTCAAAACA 120
AGTAATATTG GTTAGGGGAA AATCCCCAAC CTGCTTTTCC TTCCCACCTT CACCCATCCC 180
GCACTTTCAG GCTCCCCTTA GGGACTGTTA CCTGCAGGAG TCTTGCTAGC TTTCTAGCAA 240
CTTAACTTTG ATGTGGCTTT AAGAGAGGTG CCTGAGCTTC CATTTGCCAC ACTCTGGGGA 300
ATCCCCCAAA TGCTAACCTG TCCACTCTAC AACAAGCTCC GGCAGCTGAG CTGTTCTGGG 360
CCACCTGCCA AATATCATAT GATACTCCCT TGATGTCGGG TGACAGTAAA ATTCACCGAC 420
TCCTGGGTGG AGGCCCTTTT CTTTGAAGCC TGCTCTGCTC ACCCAACCAC ACACAGCCCA 480
CTTACACGGC ATCACCAATT AGAGTTGGGG AAATGCAGGT GGTGGCCCCG GGCTACACCA 540
AGCTCCACTG CTGCCTTGCT CTCTGGGTCA GATCTGTCTC AAGCAGAGCA AATTACTGCT 600
GGAATCACCA GGGCTGTGAG GAGCTTCAGA GAATGACCAA GGTTAGCACT TAGAGGACTG 660
AGCCCTGGGC GGTGTGCTCT AAATGTGTGT AGGGTCCTAG ATGAAGGCTT TTGGATATTT 720
CTGGTAGCAC CAAAGACTAA ACAGGCATTT GAGAAGCTTG AGGCGTCTTT GCCTGCTCCA 780
GGGCCTCCGG AAGAGGCCAC GTAGGGATGT CCCTGGGGCA TTTGCTAACT CATTCTCAGA 840
GGAAGATCCG AGGAAAATAT ATTCACTCCC TTGTCTCACT CCTTTGCTGC TCAAGCACAT 900
AAGGGTGGGT GGAAGGAGGG AGGCTAGCGA CAGCATTCCT GGTGGAGGGA GCGAGGGTAG 960
TAAGCACAGA GTGTGTTGTG ATGCAGCAAG ACAGGCTCAC TAGGACCAGA CCATGTAGTC 1020
TCAGACATAC TCCTTGGTGC 1040